These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Failure of cyprohepatdine to inhibit vasopressin-stimulated cortisol release in a patient with Cushing's disease. George WF, Husain M, Lock JP, Katz FH. Horm Res; 1976 Mar; 7(4-5):308-12. PubMed ID: 1017793 [Abstract] [Full Text] [Related]
33. Spontaneous remission of Cushing's disease after disappearance of a microadenoma attached to the pituitary stalk. Pignatta AB, Díaz AG, Gómez RM, Bruno OD. Pituitary; 2004 Mar; 7(1):45-9. PubMed ID: 15638298 [Abstract] [Full Text] [Related]
34. Cushing's disease presenting with growth failure: clinical remission during cyproheptadine therapy. Grant DB, Atherden SM. Arch Dis Child; 1979 Jun; 54(6):466-8. PubMed ID: 475431 [Abstract] [Full Text] [Related]
36. [An ACTH-secreting pituitary macroadenoma: inhibitory effect of cyproheptadine and somatostatin]. Calderón Gualda MD, Martínez de Osaba MJ, Palacín A, Vilardell E. Med Clin (Barc); 1984 Apr 28; 82(16):723-6. PubMed ID: 6145828 [No Abstract] [Full Text] [Related]
37. ACTH, beta-LPH and beta-endorphin in pituitary adenomas of the patients with Cushing's disease: activation of beta-LPH conversion to beta-endorphin. Suda T, Abe Y, Demura H, Demura R, Shizume K, Tamahashi N, Sasano N. J Clin Endocrinol Metab; 1979 Sep 28; 49(3):475-7. PubMed ID: 224076 [Abstract] [Full Text] [Related]